During the past decade, Tokeidai Memorial Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokeidai Memorial Hospital" are "Peripheral Arterial Disease" (3 trials), "Uterine Fibroids" (2 trials), "Artery Diseases, Peripheral" (1 trials), "Atherosclerosis" (1 trials) and "Endometriosis" (1 trials). Many other conditions were trialed in "Tokeidai Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Tokeidai Memorial Hospital" are "Device" (4 trials), "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vilaprisan (BAY1002670)" (3 trials), "Jetstream Atherectomy System" (2 trials), "Placebo" (2 trials), "GP1101" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokeidai Memorial Hospital" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tokeidai Memorial Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tokeidai Memorial Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tokeidai Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".